mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.32 |
0.005 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.005 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.006 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |